ABSTRACT
BACKGROUND: T1DM is divided into 1A (immune-mediated), 1B (virus-triggered, genetic and idiopathic). Presence of auto-antibodies may be correlated to glycemic control. AIM: Assessment relation between the autoantibodies and the poor glycemic control in T1DM. METHODS: 60 patients T1DM 30 males, 30 females, subjected to full history, clinical, anthropometric assessment and laboratory assessment of fasting C-peptide, FBS, 2â¯h PP glucose, HbA1c, GADA, ICA and IAA level. Classified into two groups; Group I: negative auto-antibodies, Group II: positive auto-antibodies, Group II was further classified into 3 sub-groups, Group II a:1 positive autoantibody, Group II b: 2 positive autoantibodies and Group II c: 3 positive autoantibodies. RESULTS: HbA1c was significantly higher in group II than group I (11.85⯱â¯1.61% vs. 8.52⯱â¯0.41%, pâ¯=â¯0.000). HbA1c was highest in group IIc followed by IIb then IIa (12.25⯱â¯1.48% vs. 11.57⯱â¯1.59% vs. 10.78⯱â¯1.73%, pâ¯=â¯0.038). Total insulin units per day was significantly higher in group II than group I (109.83⯱â¯7.77 U/day vs. 100.83⯱â¯1.83 U/day, pâ¯=â¯0.007). Duration of diabetes was significantly higher in group I than group II (10.17⯱â¯1.94â¯years vs. 8.11⯱â¯2.20â¯years, pâ¯=â¯0.033). HbA1c, total insulin units per day and duration of diabetes were independent predictive factors for presence of autoantibodies (pâ¯=â¯0.007, pâ¯=â¯0.033 and pâ¯=â¯0.043 respectively). CONCLUSION: Autoantibodies affect the glycemic control presented by high HbA1c; also it causes increase in total insulin units needed by patients; the more autoantibodies, the higher HbA1c, the more insulin units required to control glycemic state.